alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
#### § 183.610 Powered ventilation system.

(a) Each compartment in a boat that has a permanently installed gasoline engine with a cranking motor must:

(1) Be open to the atmosphere, or

(2) Be ventilated by an exhaust blower system.

(b) Each exhaust blower or combination of blowers must be rated at an air flow capacity not less than that computed by the formulas given in Table [183.610](/on/2024-09-23/title-33/section-183.610), Column 2. Blower rating must be determined according to AMCA Standard 210-74, Figure 12, or UL Standard 1128.

Table [183.610](/on/2024-09-23/title-33/section-183.610)

| Col. 11 | Col. 22 | Col. 33 |
| --- | --- | --- |
| Below 34 | Fr = 50 | Fo = 20 |
| 34 to 100 | Fr = 1.5V | Fo = 0.6V |
| Over 100 | Fr = V/2 + 100 | Fo = 0.2V + 40 |
| | | |
| --- | --- | --- |
| 1 Net compartment volume of engine compartment and compartments open thereto (V) cubic feet. | | |
| 2 Rated blower capacity (Fr) cubic feet per minute. | | |
| 3 Blower system output (Fo) cubic feet per minute. | | |

(c) Each exhaust blower system required by [paragraph (a)(2)](/on/2024-09-23/title-33/section-183.610#p-183.610(a)(2)) of this section must exhaust air from the boat at a rate which meets the requirements of Table [183.610](/on/2024-09-23/title-33/section-183.610), Column 3 when the engine is not operating.

(d) Each intake duct for an exhaust blower must be in the lower one-third of the compartment and above the normal level of accumulated bilge water.

(e) More than one exhaust blower may be used in combination to meet the requirements of this section.

(f) Each boat that is required to have an exhaust blower must have a label that:

(1) Is located as close as practicable to each ignition switch;

(2) Is in plain view of the operator; and

(3) Has at least the following information:

WARNING—GASOLINE VAPORS CAN EXPLODE. BEFORE STARTING ENGINE OPERATE BLOWER FOR 4 MINUTES AND CHECK ENGINE COMPARTMENT BILGE FOR GASOLINE VAPORS.
§ 1608.5 Prohibitions applicable to Corporation employees and to staff attorneys. While employed under the act, no Corporation employee and no staff attorney shall, at any time, ( a ) Use official authority or influence for the purpose of interfering with or affecting the result of an election or nomination for office, whether partisan of nonpartisan;
( b ) Directly or indirectly coerce, attempt to coerce, command or advise an employee of the Corporation or of any recipient to pay, lend, or contribute anything of value to a political party, or committee, organization, agency or person for political purposes; or
( c ) Be a candidate for partisan elective public office.
#### § 1621.2 Grievance Committee.

The governing body of a recipient shall establish a grievance committee or committees, composed of lawyer and client members of the governing body, in approximately the same proportion in which they are on the governing body.
Supreme Court of the United States

Office of the Clerk

Washington, DC 20543-0001

March 22, 2021

Clerk

United States Court of Appeals for the District of 

Columbia Circuit

333 Constitution Avenue, NW

Washington, DC 20001

Re: Level the Playing Field, et al.

v. Federal Election Commission

No. 20-649

(Your No. 19-5117)

Dear Clerk:

The Court today entered the following order in the above-entitled case:

The petition for a writ of certiorari is denied.

Sincerely,

Scott S. Harris, Clerk

Scott S. Harris

Clerk of the Court

(202) 479-3011

USCA Case #19-5117 Document #1891030 Filed: 03/22/2021 Page 1 of 1
Exhibit 31.1

Certification of CEO Pursuant to  Securities Exchange Act Rules 13a-14 and 15d-14  as Adopted Pursuant to  Section 302 of the Sarbanes-Oxley Act of 2002

I,
Timothy E. Conver, certify that:

1.     I
have reviewed this annual report on Form 10-K of AeroVironment, Inc.;

2.     Based
on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in
light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.     Based
on my knowledge, the financial statements, and other financial information included in this annual report, fairly present in all material respects the financial
condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.     The
registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act
Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15(d)-15(f))
for the registrant and have:



5.     The
registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's
auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent function):



Date: June 24, 2010

/s/ TIMOTHY E. CONVER Timothy E. Conver
Chief Executive Officer and President


---



QuickLinks
<TABLE> <S> <C>

<ARTICLE>                                           5
<CIK>                                               0001068237
<NAME>                            SSB Global Diversified Futures Fund L.P.

<S>                                                   <C>
<PERIOD-TYPE>                                       6-MOS
<FISCAL-YEAR-END>                                   DEC-31-1999
<PERIOD-START>                                      JAN-01-1999
<PERIOD-END>                                        JUN-30-1999
<CASH>                                                        54,956,533
<SECURITIES>                                                   2,028,976
<RECEIVABLES>                                                    158,040
<ALLOWANCES>                                                           0
<INVENTORY>                                                            0
<CURRENT-ASSETS>                                              57,143,549
<PP&E>                                                                 0
<DEPRECIATION>                                                         0
<TOTAL-ASSETS>                                                57,143,549
<CURRENT-LIABILITIES>                                          1,156,385
<BONDS>                                                                0
<PREFERRED-MANDATORY>                                                  0
<PREFERRED>                                                            0
<COMMON>                                                               0
<OTHER-SE>                                                    55,987,164
<TOTAL-LIABILITY-AND-EQUITY>                                  57,143,549
<SALES>                                                                0
<TOTAL-REVENUES>                                                (102,006)
<CGS>                                                                  0
<TOTAL-COSTS>                                                          0
<OTHER-EXPENSES>                                               1,273,830
<LOSS-PROVISION>                                                       0
<INTEREST-EXPENSE>                                                     0
<INCOME-PRETAX>                                               (1,375,836)
<INCOME-TAX>                                                           0
<INCOME-CONTINUING>                                                    0
<DISCONTINUED>                                                         0
<EXTRAORDINARY>                                                        0
<CHANGES>                                                              0
<NET-INCOME>                                                  (1,375,836)
<EPS-BASIC>                                                     (13.15)
<EPS-DILUTED>                                                          0



</TABLE>
§ 1631.18 Insurance. At the time of purchase, a recipient must obtain insurance coverage for real estate purchased with LSC funds which is not lower in value than coverage it has obtained for other real estate it owns and which provides at least the following coverage: ( a ) Title insurance that: ( 1 ) Insures the fee interest in the property for an amount not less than the full appraised value as approved by LSC, or the amount of the purchase price, whichever is greater; and
( 2 ) Contains an endorsement identifying LSC as a loss payee to be reimbursed if the title fails.
( 3 ) If no endorsement naming LSC as loss payee is made, the recipient must pay LSC the title insurance proceeds it receives in the event of a failure.
( b ) A physical destruction insurance policy, including flood insurance where appropriate, which insures the full replacement value of the facility from risk of partial and total physical destructions. The recipient must maintain this policy for the period of time that the recipient owns the real estate.
##### 



Certification Pursuant to Section 302
of the Sarbanes-Oxley Act of 2002
  1.
    
    I have reviewed this Amendment No. 1 to the quarterly report on Form 10-Q/A of MetroCorp Bancshares, Inc.;2.
    
    Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to
state a material fact necessary to make the statements made, in light of the circumstances under which
such statements were made, not misleading with respect to the period covered by this report;3.
    
    Based on my knowledge, the financial statements, and other financial information included in this report,
fairly present in all material respects the financial condition, results of operations and cash flows of
the registrant as of, and for, the periods presented in this report;4.
    
    The registrants other certifying officers and I are responsible for establishing and maintaining
disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the
registrant and have:
 a)
    
    designed such disclosure controls and procedures, or caused such
disclosure controls and procedures to be designed under our
supervision, to ensure that material information relating to the
registrant, including its consolidated subsidiaries, is made known
to us by others within those entities, particularly during the
period in which this report is being prepared;b)
    
    evaluated the effectiveness of the registrants disclosure
controls and procedures and presented in this report our
conclusions about the effectiveness of the disclosure controls and
procedures, as of the end of the period covered by this report
based on such evaluation; andc)
    
    disclosed in this report any change in the registrants internal
control over financial reporting that occurred during the
registrants most recent fiscal quarter (the registrants fourth
fiscal quarter in the case of an annual report) that has
materially affected, or is reasonably likely to materially affect,
the registrants internal control over financial reporting; and
 5.
    
    The registrants other certifying officer(s) and I have disclosed,
based on our most recent evaluation of internal control over
financial reporting, to the registrants auditors and the audit
committee of the registrants board of directors (or persons
performing the equivalent functions):
 a)
    
    all significant deficiencies and material weaknesses in the design or
operation of internal control over financial reporting which are
reasonably likely to adversely affect the registrants ability to
record, process, summarize and report financial information; andb)
    
    any fraud, whether or not material, that involves management or other
employees who have a significant role in the registrants internal
control over financial reporting.
 Date: March 14, 2006/s/ George M. LeeGeorge M. LeeChief Executive Officer
#### § 158.350 Subsequent requests for adjustment to the medical loss ratio.

A State that has made a previous request for an adjustment to the MLR standard must, in addition to the other information required by this subpart, submit information as to what steps the State has taken since its prior requests, if any, to improve the stability of the State's individual market.

[83 FR 17071, Apr. 17, 2018]
##### 



Exhibit 31.2 Certification Pursuant to Section 302
Of the Sarbanes-Oxley Act of 2002  I, David D. Rinehart, certify that:1.
    
    I have reviewed this quarterly report on Form 10-Q of MetroCorp
Bancshares, Inc.;2.
    
    Based on my knowledge, this report does not contain any untrue statement
of a material fact or omit to state a material fact necessary to make the
statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this
report;3.
    
    Based on my knowledge, the financial statements, and other financial
information included in this report, fairly present in all material
respects the financial condition, results of operations and cash flows of
the registrant as of, and for, the periods presented in this report;4.
    
    The registrants other certifying officers and I are responsible for
establishing and maintaining disclosure controls and procedures (as
defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant
and have:  a)
    
    designed such disclosure controls and procedures, or caused
such disclosure controls and procedures to be designed under our
supervision, to ensure that material information relating to the
registrant, including its consolidated subsidiaries, is made known
to us by others within those entities, particularly during the
period in which this report is being prepared;b)
    
    evaluated the effectiveness of the registrants disclosure
controls and procedures and presented in this report our conclusions
about the effectiveness of the disclosure controls and procedures,
as of the end of the period covered by this report based on such
evaluation; andc)
    
    disclosed in this report any change in the registrants
internal control over financial reporting that occurred during the
registrants most recent fiscal quarter (the registrants fourth
fiscal quarter in the case of an annual report) that has materially
affected, or is reasonably likely to materially affect, the
registrants internal control over financial reporting; and  5.
    
    The registrants other certifying officer(s) and I have disclosed, based
on our most recent evaluation of internal control over financial
reporting, to the registrants auditors and the audit committee of the
registrants board of directors (or persons performing the equivalent
functions):  a)
    
    all significant deficiencies and material weaknesses in the
design or operation of internal control over financial reporting
which are reasonably likely to adversely affect the registrants
ability to record, process, summarize and report financial
information; andb)
    
    any fraud, whether or not material, that involves management
or other employees who have a significant role in the registrants
internal control over financial reporting. Date: May 13, 2004 /s/ David D. Rinehart
# PAC Table 2a
```

[Federal Register Volume 71, Number 21 (Wednesday, February 1, 2006)]
[Notices]
[Pages 5347-5348]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 06-913]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health

National Cancer Institute; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as

[[Page 5348]]

amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The contract proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, SBIR Topic 222, ``Investigation of the Production Parameters 
of Microbial Natural Product''.
    Date: March 9, 2006.
    Time: 8:45 a.m. to 10 a.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6116 Executive Boulevard, 
Rockville, MD 20852, (Telephone Conference Call).
    Contact Person: Marvin L. Salin, PhD, Scientific Review 
Administrator, Special Review and Logistics Branch, Division of 
Extramural Activities, 6116 Executive Boulevard, Room 7073, MSC8329, 
Bethesda, MD 20892-8329, 301-496-0694, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research, 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: January 24, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 06-913 Filed 1-31-06; 8:45 am]
BILLING CODE 4140-01-M
```
EXHIBIT 4.3

                         FORM OF STOCK AWARD TAX NOTICE


<PAGE>



                 TAX ISSUES RELATED TO EXERCISE OF STOCK OPTIONS


         This   memorandum   reviews  the  tax  effects  upon  the  exercise  of
"Non-Incentive  Stock Options"  ("NSOs")  (those options awarded to non-employee
directors and perhaps to some officers).

         Upon the  exercise of an NSO, the amount by which the fair market value
of the shares on the date of exercise  exceeds the exercise  price will be taxed
to the optionee as ordinary income.  The Company will be entitled to a deduction
in  the  same  amount,  provided  it  makes  all  required  withholdings  on the
compensation  element of the exercise.  In general,  the optionee's tax basis in
the shares  acquired by  exercising  an NSO is equal to the fair market value of
such shares on the date of exercise.  Upon a subsequent  sale of any such shares
in a  taxable  transaction,  the  optionee  will  realize  capital  gain or loss
(long-term  or  short-term,  depending  on whether the shares were held for more
than 12 months before the sale) in an amount equal to the difference between his
or her basis in the shares and the sale price.

         Special  rules  apply if an  optionee  pays  the  exercise  price  upon
exercise of NSOs with previously  acquired shares of stock.  Except as described
below with respect to shares  acquired  pursuant to ISOs,  such a transaction is
treated as a  tax-free  exchange  of the old  shares for the same  number of new
shares.  To that extent,  the optionee's  basis in the new shares is the same as
his or her basis in the old shares, i.e., there is a carryover of basis, and the
capital gain holding period runs without interruption from the date when the old
shares were  acquired.  The value of any new shares  received by the optionee in
excess of the number of old shares  surrendered  less any cash the optionee pays
for the new shares will be taxed as ordinary income. The optionee's basis in the
additional  shares is equal to the fair market  value of such shares on the date
the shares were  transferred,  and the capital gain holding period  commences on
the same date.  The effect of these  rules is to defer the date when any gain in
the old  shares  that  are used to buy new  shares  must be  recognized  for tax
purposes.  Stated  differently,  these  rules  allow an  optionee to finance the
exercise of an NSO by using shares of stock that he or she already owns, without
paying  current  tax on any  unrealized  appreciation  in the  value of all or a
portion of those old shares.
IIA 

118TH CONGRESS 

2D SESSION S. J. RES. 118 

Providing for congressional disapproval of the proposed foreign military sale 

to the Government of the United Arab Emirates of certain defense 

articles and services. 

IN THE SENATE OF THE UNITED STATES 

NOVEMBER 21, 2024 

Mr. VAN HOLLEN introduced the following joint resolution; which was read 

twice and referred to the Committee on Foreign Relations 

JOINT RESOLUTION 

Providing for congressional disapproval of the proposed foreign military sale to the Government of the United Arab 

Emirates of certain defense articles and services. 

1 Resolved by the Senate and House of Representatives

2 of the United States of America in Congress assembled, 

3 That the following proposed foreign military sale to the 

4 Government of the United Arab Emirates is prohibited: 

5 (1) The sale of the following defense articles 

6 and services, described in Transmittal No. 20–79, 

7 submitted to Congress pursuant to section 36(b)(1) 

8 of the Arms Export Control Act (22 U.S.C. 

9 2776(b)(1)), and published in the Congressional 


ssavage on LAPJG3WLY3PROD with BILLS
2 

•SJ 118 IS 

1 Record on November 20, 2024: two hundred fifty2 nine (259) Guided Multiple Launch Rocket System 

3 (GMLRS) M31A1 Unitary Pods (1,554 missiles at 

4 six missiles per pod) and two hundred three (203) 

5 Army Tactical Missile Systems (ATACMS) M57 

6 Unitary Missiles. Also included are publications; per7 sonnel training and training equipment; software de8 velopment; U.S. Government and contractor engi9 neering, technical and logistics support services; and 

10 other related elements of logistical and program sup11 port. 

Æ 


ssavage on LAPJG3WLY3PROD with BILLS